Applicant *** v Amycel (CoA, 16 January 2026)
| Date | 16 January 2026 |
|---|---|
| Court | CoA |
| Division | Luxembourg (LU) |
| Type of action | Application Rop 223 |
| Case number(s) | UPC_CoA_935/2025 |
| Registry reference | UPC_CoA_000935/2025 |
| Parties | Applicant *** v. Amycel, LLC |
Official decision (PDF) · UPC registry entry
Case timeline
- 24 March 2026 : Applicant *** v Amycel (CoA, 24 March 2026) UPC-COA-0000935/2025
- 3 September 2026 : Name not displayed for GDPR reasons. Represented by Michal PRZYLUSKI v Amycel (CoA, 3 September 2026) UPC-COA-0000935/2025
- 2 November 2026 : Appellant v Amycel (CoA, UPC_CoA_935/2025, 2 November 2026) UPC-COA-0000935/2025
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
By an order of 16 January 2026 (UPC_CoA_935/2025), the Court of Appeal refused suspensive effect for the appeal against The Hague Local Division’s default decision of 21 October 2025, which found that the « Cayene » mushroom strain infringed Amycel’s EP 1 993 350. The appellant targeted the orders to inform customers by registered letter, to publish a notice on its website and to pay EUR 50,000 as an interim award of damages. The order confirms that general assertions of irreversibility or serious consequences are not enough.
Question
Do the alleged irreversibility of the information and publication measures, and uncertainty over repayment of an interim award, justify suspensive effect for the appeal under Art. 74(1) UPCA?
Decision
An appeal has no suspensive effect unless exceptional circumstances make the appellant’s interest in maintaining the status quo prevail, for example where the decision is manifestly erroneous or the appeal would otherwise become devoid of purpose (paragraphs 10 and 11). The applicant must establish them (paragraph 12). The appellant did not show that the decision was manifestly erroneous. Even if the letters and the publication are not fully reversible, the appeal does not lose its purpose and Amycel’s interest in informing customers prevails (paragraph 13). A bare reference to « serious consequences » of payment, without further substantiation, is insufficient (paragraph 14). The court ruled without hearing Amycel, as Rule 223.3 requires a decision without delay (paragraph 15).
Key points for practice
- A request for suspensive effect must show concretely a manifest error or that the appeal would become devoid of purpose. Partial irreversibility of a publication is not enough.
- The financial risk of paying an interim award must be quantified and substantiated.
Provisions applied
- Agreement on a Unified Patent Court
- Art. 74(1)
- Rules of Procedure
- Rules 223, 275.3(b) and 355
- Case law cited
- Suinno Mobile & AI Licensing v Microsoft, Court of Appeal, 24 November 2025, Chint New Energy v Jingao, Court of Appeal, 20 May 2025
Related decisions
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Decisions in the same proceedings
Going further
Lexicon: UPC Court of Appeal.
Dhenne Avocats blog: UPC Appeals: What the Numbers Show.
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Parties
- defendantAmycel, LLC8 decisions in the corpusFollow this party
- claimantApplicant ***11 decisions in the corpusFollow this party
Decisions in the same proceedings and documented appeals
- 16 January 2026 Applicant *** v Amycel (CoA, 16 January 2026) Application Rop 223 · UPC_CoA_935/2025
- 24 March 2026 Applicant *** v Amycel (CoA, 24 March 2026) Application Rop 223 · UPC_CoA_935/2025
La seconde demande d'effet suspensif, présentée le 20 février 2026, est irrecevable, faute de reposer sur des éléments qui ne pouvaient être présentés avec la première.
- 3 September 2026 Name not displayed for GDPR reasons. Represented by Michal PRZYLUSKI v Amycel (CoA, 3 September 2026) Appeal · UPC_CoA_935/2025
La demande d'interprétation anglais-polonais de l'appelant, personne physique représentée, est rejetée. Il peut recourir à ses frais à un interprète en informant le greffe avant le 9 septembre 2026.
What the record states
- Nature of the act
- Application Rop 223
- Outcome (Dhenne Avocats summary)
- La demande d'effet suspensif est rejetée : l'appelant n'établit ni une erreur manifeste de la décision par défaut ni la perte d'objet de l'appel, et ses affirmations sur les conséquences du paiement ne sont pas étayées.
- Appeal
- Decision of the Court of Appeal.
- Instance
- Court of Appeal decision.
Patents mentioned
EP 1 993 350mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- Name not displayed for GDPR reasons. Represented by Michal PRZYLUSKI v Amycel (CoA, 3 September 2026) cited in this record
- *** v AMYCEL (CoA, 2 July 2026) cited in this record
- Applicant *** v Amycel (CoA, 24 March 2026) cited in this record
- Suinno Mobile & AI Technologies Licensing v Microsoft (CoA, 24 November 2025) cited in this record
- Amycel v XXX (CFI, 21 October 2025) cited in this record
- Chint New Energy v JingAo Solar (CoA, 20 May 2025) cited in this record
- ALPINA Coffee Systems v CUP&CINO Kaffeesystem-Vertrieb (CoA, 24 March 2026) cites this decision
- Appellant v Amycel (CoA, UPC_CoA_935/2025, 2 November 2026) cites this decision
Patents and standards
| Publication | Role in the dispute | Family | Standard and declaration | Pool | Sources |
|---|---|---|---|---|---|
EP 1 993 350Brown mushrooms for commercial production recorded proprietor: Amycel LLC | Mentioned in the analysis (role not qualified) Also mentioned in 11 other decision(s): Name not displayed for GDPR reasons. Represented by Michal PRZYLUSKI v · *** v AMYCEL (CoA, 2 July 2026) · Applicant *** v Amycel (CoA, 24 March 2026) · Amycell v *** (CFI, 9 December 2025) · Amycel v XXX (CFI, 21 October 2025) · Amycel v *** (CFI, 1 April 2025) · Amycel v *** (CFI, 18 December 2024) · *** v Amycel (CoA, 28 November 2024) | not recorded | not recorded | not recorded | Espacenet · European Patent Register existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically) mentioned in: Dhenne Avocats analysis |
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.